Adherence to treatment and anticoagulation control in vitamin K antagonists-treated patients: an administrative databases analysis in a large Italian population

Adherence to treatment and anticoagulation control in vitamin K antagonists-treated patients: an administrative databases analysis in a large Italian population

Authors

  • Luca Degli Esposti CliCon S.r.l. Health, Economics and Outcomes Research, Ravenna
  • Diego Sangiorgi CliCon S.r.l. Health, Economics and Outcomes Research, Ravenna
  • Giuseppe Di Pasquale Unità Operativa di Cardiologia. Ospedale Maggiore, Bologna
  • Gian Franco Gensini Dipartimento di Area Critica Medico-Chirurgica, Università degli Studi di Firenze, Azienda Ospedaliero-Universitaria, Careggi Fondazione Don Carlo Gnocchi, Onlus IRCCS, Impruneta, Firenze
  • Ido Iori Medicina Interna I, Centro Emostasi e Trombosi-Stroke Unit, Azienda Ospedaliera A.S.M.N., Reggio Emilia
  • Stefano Buda CliCon S.r.l. Health, Economics and Outcomes Research, Ravenna
  • Ezio Degli Esposti CliCon S.r.l. Health, Economics and Outcomes Research, Ravenna

DOI:

https://doi.org/10.7175/fe.v12i2.71

Keywords:

Adherence to treatment, Anticoagulation control, INR, Vitamin K antagonists, Administrative databases

Abstract

Oral anticoagulant therapy is essential for the treatment and prevention of many thromboembolic disorders. The aim of the present study is to evaluate the level of anticoagulation intensity in patients treated with vitamin K antagonists (VKAs) in a clinical practice setting and to explore the relationship between anticoagulation intensity and adherence to VKA treatment. We conducted a retrospective cohort study using the administrative databases of three Italian Local Health Units. Patients were enrolled if they had filled at least one prescription for VKAs (ATC code B01AA) between January 1st, 2007 and June 30th, 2008. In the same period all determinations of the international normalised ratio (INR) were collected. The parameters evaluated were anticoagulation control and adherence to VKA treatment.

The survey showed that only 47.9% and 56.3% of INR determinations, in VKA naïve and established patients respectively, were into the recommended range (2.0-3.0). Moreover, the percentage of INR determination below the recommended range was higher than the percentage of INR determination above the recommended range for both naïve and established patients. Moreover, adherence to VKA treatment was poor both in naïve and established patients and, consequently, anticoagulation control is poor. Also in patients with the highest adherence to VKA treatment, only about 60% of INR determinations were into the recommended range. Our findings evidence that the anticoagulation control in clinical practice settings is still unsatisfactory and it is necessary to evaluate interventions to increase the amount of time at which patients’ INR are within the recommended range.

Author Biography

Stefano Buda, CliCon S.r.l. Health, Economics and Outcomes Research, Ravenna

This study was funded by Boehringer-Ingelheim Italy

Downloads

Published

2011-06-15

How to Cite

Degli Esposti, L., Sangiorgi, D., Di Pasquale, G., Gensini, G. F., Iori, I., Buda, S., & Degli Esposti, E. (2011). Adherence to treatment and anticoagulation control in vitamin K antagonists-treated patients: an administrative databases analysis in a large Italian population. Farmeconomia. Health Economics and Therapeutic Pathways, 12(2), 53–59. https://doi.org/10.7175/fe.v12i2.71

Issue

Section

Original research

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >> 
Loading...